BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Open accessThe DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Abstract
Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are only gradually being understood. This narrative review provides an up-to-date overview of the interplay between antidepressant treatment and Brain-Derived Neurotrophic Factor (BDNF) signaling. In addition, the impact of nutritional, environmental and physiological factors on BDNF and the antidepressant response is outlined. This review underlines the necessity to include information on lifestyle choices in testing and developing antidepressant treatments in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), have been shown to increase BDNF levels both in peripheral blood and in specific brain regions such as the hippocampus, which is critical for mood regulation and neurogenesis [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conventional antidepressants, particularly SSRIs and SNRIs, are known to increase BDNF levels over time, which correlates with their delayed therapeutic effect [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“Studies on gene-environment interactions may not only help to understand the pathophysiology of MDD but could also provide predictive factors for personalized antidepressant therapy [162,163].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Environmental conditions, including stressful or traumatic events are known risk factors to depression [170].”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 1×
“Cortisol is increased in patients suffering from MDD [172] and is thought to impair serotonin transmission [173].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“The first studies unveiling the involvement of BDNF in antidepressant response showed that chronic administration of conventional antidepressant drugs, including tranylcypromine, sertraline, desipramine, and mianserin, significantly increased BDNF mRNA expression in the hippocampus and cortical regions, counteracting…”
BackgroundNeurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060 · cited 2×
“BDNF is a crucial regulator of neurite outgrowth, synaptic plasticity, and the selection of functional neuronal connections in the central nervous system [20,31,32], that mediates the plastic changes induced by antidepressants [6].”
BackgroundThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Nanni, V., Uher, R., & Danese, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020335 · Cited by 1,480
NEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · cited 1×
“BDNF is a crucial regulator of neurite outgrowth, synaptic plasticity, and the selection of functional neuronal connections in the central nervous system [20,31,32], that mediates the plastic changes induced by antidepressants [6].”
BackgroundNibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Function and Mechanism of Zinc Metalloenzymes
McCall, K. A., Huang, C.-C., & Fierke, C. A. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.5.1437s · Cited by 1,136
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · cited 1×
“including monoaminergic drugs and ketamine share BDNF-mediated neuroanatomical effects [11,12].”
BackgroundStressful life events, genetic liability, and onset of an episode of major depression in women
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.833 · Cited by 1,063
Duncan, L. E., & Keller, M. C. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020191 · Cited by 1,032
The serotonin theory of depression: a systematic umbrella review of the evidence
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01661-0 · Cited by 960
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · cited 2×
“BDNF is a crucial regulator of neurite outgrowth, synaptic plasticity, and the selection of functional neuronal connections in the central nervous system [20,31,32], that mediates the plastic changes induced by antidepressants [6].”
BackgroundMagnesium metabolism and its disorders.
Swaminathan, R. (2003) · PubMed · Cited by 950
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841
Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dunner, D. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336126100 · Cited by 829
Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820
Sleiman, S. F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S. S., Holson, E. B., Ratan, R. R., et al. (2016) · eLife · doi:10.7554/elife.15092 · Cited by 810
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Exercise for the treatment of depression and anxiety
Carek, P. J., Laibstain, S. E., & Carek, S. M. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.1.c · Cited by 797 · cited 1×
“In addition, sport or physical activities are beneficial for depression treatment [188].”
BackgroundPostsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease
Yoshii, A., & Constantine‐Paton, M. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20765 · Cited by 744
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634
Nemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
Peet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 614
Omega-3 fatty acids in major depressive disorder
Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00032-4 · Cited by 596
Homocysteine, folate, methylation, and monoamine metabolism in depression
Bottiglieri, T. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.2.228 · Cited by 546
Dendritic Spines in Depression: What We Learned from Animal Models
Qiao, H., Li, M.-X., Xu, C., Chen, H.-B., An, S.-C., & Ma, X.-M. (2016) · Neural Plasticity · doi:10.1155/2016/8056370 · Cited by 446
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436 · cited 1×
“Clinical data demonstrated the efficacy of adjunctive S-adenosyl methionine use to improve antidepressant response [73,114,115], even in case of selective serotonin reuptake inhibitor (SSRI)-treatment resistant patients [116].”
Background[Magnesium metabolism and its disorders].
Madrenas Puig, J., Pigrau, C., & Vázquez, J. M. M. (1986) · PubMed · Cited by 427
Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420
Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380
What has serotonin to do with depression?
Cowen, P. J., & Browning, M. (2015) · World Psychiatry · doi:10.1002/wps.20229 · Cited by 374
Duman, R. S., & Li, N. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0357 · Cited by 362
Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016) · Psychological Medicine · doi:10.1017/s0033291716000064 · Cited by 359 · cited 1×
“As a game changer in this scenario, the dissociative anesthetic and N-methyl-D-aspartate (NMDA) receptor inhibitor ketamine showed rapid and sustained antidepressant action in clinical trials [9] and the (S)-ketamine nasal spray has been developed and approved in the United States and Europe for the employment in trea…”
BackgroundGenome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Uher, R., Perroud, N., Ng, M. Y. M., Hauser, J., Henigsberg, N., Maier, W., Mors, O., Placentino, A., Rietschel, M., Souery, D., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09070932 · Cited by 350
Valproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345
Mamounas, L. A., Altar, C. A., Blue, M. E., Kaplan, D. R., Tessarollo, L., & Lyons, W. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00771.2000 · Cited by 344
Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update
Leßmann, V., & Brigadski, T. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.06.004 · Cited by 337
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337 · cited 1×
“5 mg/d Fluoxetine 20 mg/d HDRS: Folic acid < placebo [126] Folic acid 10 mg/d Fluoxetine 20 mg/d HDRS: Folic acid < placebo [127] Folic acid 5 mg/d Unspecified antidepressants BDI-II: Folic acid = placebo [131] Folic acid 2 mg/d + Vitamin B12 0.”
MethodDiscovery of human zinc deficiency: 50 years later
Prasad, A. S. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.04.004 · Cited by 335
Balkowiec, A., & Katz, D. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07417.2000 · Cited by 332
Ising, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306
Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09081198 · Cited by 297
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Garriock, H. A., Kraft, J. B., Shyn, S. I., Peters, E. J., Yokoyama, J. S., Jenkins, G. D., Reinalda, M. S., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.029 · Cited by 288
Neuronal plasticity and neurotrophic factors in drug responses
Castrén, E., & Antila, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.61 · Cited by 284
Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11071114 · Cited by 275
Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression
Kang, H.-J., Kim, J.-M., Stewart, R., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Shin, M.-G., & Yoon, J.-S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.006 · Cited by 254
Esvald, E.-E., Tuvikene, J., Sirp, A., Patil, S., Bramham, C. R., & Timmusk, T. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0367-19.2019 · Cited by 248
Ketamine: A tale of two enantiomers
Jelen, L. A., Young, A. H., & Stone, J. M. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959644 · Cited by 246
Nutritional Aspects of Depression
Lang, U. E., Beglinger, C., Schweinfurth, N., Walter, M., & Borgwardt, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430229 · Cited by 239
(2003) · PubMed · Cited by 236
Wook Koo, J., Labonté, B., Engmann, O., Calipari, E. S., Juarez, B., Lorsch, Z., Walsh, J. J., Friedman, A. K., Yorgason, J. T., Han, M.-H., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.009 · Cited by 231
Self-citationJazayeri, S., Tehrani-Doost, M., Keshavarz, S. A., Hosseini, M., Djazayery, A., Amini, H., Jalali, M., & Peet, M. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701827275 · Cited by 215
Siwek, M., Dudek, D., Paul, I. A., Sowa-Kućma, M., Zięba, A., Popik, P., Pilc, A., & Nowak, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.014 · Cited by 210
Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
Silvers, K. M., Woolley, C. C., Hamilton, F. C., Watts, P. M., & Watson, R. A. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.11.004 · Cited by 207
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207 · cited 1×
“Hence, individualized therapy is gaining importance, as the sum of genetic risk and environmental factors results in a differential and individual response to antidepressants [168,169].”
BackgroundTrepanowski, J. F., Canale, R. E., Marshall, K. E., Kabir, M. M., & Bloomer, R. J. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-107 · Cited by 204
Pandey, G. N., Ren, X., Rizavi, H. S., Conley, R. R., Roberts, R. C., & Dwivedi, Y. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009000 · Cited by 203
Horstmann, S., Lucae, S., Menke, A., Hennings, J. M., Ising, M., Roeske, D., Müller-Myhsok, B., Holsboer, F., & Binder, E. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.180 · Cited by 183
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response
Domschke, K., Tidow, N., Schwarte, K., Deckert, J., Lesch, K.-P., Arolt, V., Zwanzger, P., & Baune, B. T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400039x · Cited by 178
Wu, A., Ying, Z., & Gomez-Pinilla, F. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0313 · Cited by 178
Tadić, A., Müller-Engling, L., Schlicht, K. F., Kotsiari, A., Dreimüller, N., Kleimann, A., Bleich, S., Lieb, K., & Frieling, H. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.58 · Cited by 175
Nowak, G., Szewczyk, B., Wieronska, J. M., Branski, P., Palucha, A., Pilc, A., Sadlik, K., & Piekoszewski, W. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00104-7 · Cited by 171
Potentiation of a monoamine oxidase inhibitor by tryptophan
Glassman, A. H., & Platman, S. R. (1969) · Journal of Psychiatric Research · doi:10.1016/0022-3956(69)90013-2 · Cited by 169
Folate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Taylor, M. J., Carney, S. M., Goodwin, G. M., & Geddes, J. R. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042630 · Cited by 163
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses
Papakostas, G. I., Öngür, D., Iosifescu, D. V., Mischoulon, D., & D, M. F. M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00099-3 · Cited by 163
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3b5f · Cited by 162 · cited 2×
“4 g/d Citalopram 20–40 mg/d HDRS: Fatty acids < placebo [88] EPA 0.”
BackgroundClinically Significant Drug Interactions with Antidepressants in the Elderly
Spina, E., & Scordo, M. G. (2002) · Drugs & Aging · doi:10.2165/00002512-200219040-00004 · Cited by 157
Ma, Z., Zang, T., Birnbaum, S. G., Wang, Z., Johnson, J. E. B., Zhang, C., & Parada, L. F. (2017) · Nature Communications · doi:10.1038/s41467-017-01709-8 · Cited by 152
Stressful Life Events, Genetic Liability, and Onset of an Episode of Major Depression in Women
Kendler, K. S., Kessler, R. C., Walters, E. E., MacLean, C., Neale, M. C., Heath, A. C., & Eaves, L. J. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.3.foc459 · Cited by 150
Sales, A. J., Biojone, C., Terceti, M. S., Guimarães, F. S., Gomes, M. V., & Joca, S. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01489.x · Cited by 147
Khoraminya, N., Tehrani-Doost, M., Jazayeri, S., Hosseini, A., & Djazayery, A. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412465022 · Cited by 145
Branchi, I., D’Andrea, I., Sietzema, J. G., Fiore, M., Fausto, V. D., Aloe, L., & Alleva, E. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20789 · Cited by 145
Jang, S.-W., Liu, X., Chan, C.-B., Weinshenker, D., Hall, R. A., Xiao, G., & Ye, K. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.010 · Cited by 144 · cited 5×
“The monoaminergic an‐ tidepressant‐induced neuronal events, i l t progre sive 5‐HT r ceptor down‐ regulation, thus decreased fu ctional inhibition of TrkB, a d the intrac llula ev nts triggered by direct TrkB modulation, are in accordanc with th slow devel pment of the clinical antidep sa t response.”
BackgroundInfluentialCarney, R. M., Freedland, K. E., Rubin, E. H., Rich, M. W., Steinmeyer, B. C., & Harris, W. S. (2009) · JAMA · doi:10.1001/jama.2009.1487 · Cited by 141
Potentiation of the Antidepressant Action of Clomipramine by Tryptophan
Wålinder, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770110112012 · Cited by 136
Banerjee, R., Ghosh, A. K., Ghosh, B., Bhattacharyya, S., & Mondal, A. C. (2013) · Clinical Medicine Insights: Pathology · doi:10.4137/cpath.s12530 · Cited by 135
Ketoconazole administration in hypercortisolemic depression
Wolkowitz, O. M., Reus, V. I., Manfredi, F., INGBAR, J. C., Brizendine, L., & Weingartner, H. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.5.810 · Cited by 134
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment
Siwek, M., Dudek, D., Schlegel-Zawadzka, M., Morawska, A., Piekoszewski, W., Opoka, W., Zięba, A., Pilc, A., Popik, P., & Nowak, G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.024 · Cited by 132
Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005766 · Cited by 132
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
Papakostas, G. I., & Ionescu, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.92 · Cited by 129
Vines, A., Delattre, A. M., Lima, M. M. S., Rodrigues, L. S., Suchecki, D., Machado, R. B., Tufik, S., Pereira, S. I. R., Zanata, S. M., & Ferraz, A. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.017 · Cited by 129
Neurotrophin Receptor Activation and Expression in Human Postmortem Brain: Effect of Suicide
Dwivedi, Y., Rizavi, H. S., Zhang, H., Mondal, A. C., Roberts, R. C., Conley, R. R., & Pandey, G. N. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.035 · Cited by 128
Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124 · cited 2×
“The effects of monoaminergic antidepressants and ketamine on TrkB signaling have long been considered indirect, caused by the inhibition of monoamine transporters and NMDA receptors, respectively, and mediated by the increase in BDNF expression and release [19].”
BackgroundLyoo, I. K., Yoon, S., Kim, T.-S., Hwang, J., Kim, J. E., Won, W., Bae, S., & Renshaw, P. F. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010009 · Cited by 123
Jurič, D. M., Lončar, D., & Čarman‐Kržan, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.035 · Cited by 119
Seo, M. K., Ly, N. N., Lee, C. H., Cho, H. Y., Choi, C. M., Nhu, L. H., Lee, J. G., Lee, B. J., Kim, G.-M., Yoon, B. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.009 · Cited by 116
Oh, H., Lewis, D. A., & Sibille, E. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.126 · Cited by 115
Banerjee, R., Ghosh, A. K., Ghosh, B., et al. (2013) · PubMed · doi:10.4137/cmpath.s12530 · Cited by 113
Role of Mesolimbic Brain-Derived Neurotrophic Factor in Depression
Koo, J. W., Chaudhury, D., Han, M.-H., & Nestler, E. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.020 · Cited by 112 · cited 1×
“As such, while BDNF exerts an antidepressant effect in the prefrontal cortex [43] and hippocampus [36], an opposite role has been highlighted in the mesolimbic circuit, including dopamine projections from the ventral tegmental area to the nucleus accumbens [44,45].”
BackgroundAmr, M., El-Mogy, A., Shams, T., Vieira, K. F., & Lakhan, S. E. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-31 · Cited by 111
Zheng, Y., Fan, W., Zhang, X., & Dong, E. (2016) · Epigenetics · doi:10.1080/15592294.2016.1146850 · Cited by 111 · cited 1×
“For instance, in rodents, stress in utero increased methylation at Bdnf promoters, which was associated with a reduced Bdnf transcription and increased depressive-like behaviors in tail suspension, forced swim, and sucrose preference tests [181].”
BackgroundNavailles, S., Hof, P. R., & Schmauss, C. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21775 · Cited by 108
Activity-Dependent Activation of TrkB Neurotrophin Receptors in the Adult CNS
Aloyz, R., Fawcett, J. P., Kaplan, D. R., Murphy, R. A., & Miller, F. D. (1999) · Learning & Memory · doi:10.1101/lm.6.3.216 · Cited by 107
Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test
Fitzgerald, P. J., Yen, J. Y., & Watson, B. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215554 · Cited by 107
Antidepressants in elderly: Metaregression of double-blind, randomized clinical trials
Calati, R., Signorelli, M. S., Balestri, M., Marsano, A., Ronchi, D. D., Aguglia, E., & Serretti, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.053 · Cited by 105
Mozaffari–Khosravi, H., Yassini-Ardakani, M., Karamati, M., & Shariati-Bafghi, S.-E. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.003 · Cited by 104
Jin, H.-J., Pei, L., Li, Y.-N., Zheng, H., Yang, S., Wan, Y., Mao, L., Xia, Y.-P., He, Q.-W., Li, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13929-5 · Cited by 96
Jahangard, L., Sadeghi, A., Ahmadpanah, M., Holsboer‐Trachsler, E., Bahmani, D. S., Haghighi, M., & Brand, S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.016 · Cited by 95
Młyniec, K., & Nowak, G. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70762-4 · Cited by 94
Almeida, O. P., Ford, A. H., Hirani, V., Singh, V., VANBOCKXMEER, F., McCaul, K. A., & Flicker, L. A. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.145177 · Cited by 93
Ranjbar, E., Shams, J., Sabetkasaei, M., M-Shirazi, M., Rashidkhani, B., Mostafavi, A., Bornak, E., & Nasrollahzadeh, J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000066 · Cited by 92
Vitamin B12 Supplementation in Treating Major Depressive Disorder: A Randomized Controlled Trial
Syed, E. U., Wasay, M., & Awan, S. (2013) · The Open Neurology Journal · doi:10.2174/1874205x01307010044 · Cited by 90
Galter, D., & Unsicker, K. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0841 · Cited by 86
Kondo, D. G., Sung, Y.-H., Hellem, T. L., Fiedler, K. K., Shi, X., Jeong, E.-K., & Renshaw, P. F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.010 · Cited by 86
Folate and Unipolar Depression
Morris, D. W., Trivedi, M. H., & Rush, A. J. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.0663 · Cited by 85
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels
Zimmermann, N., Zschocke, J., Perišić, T., Yu, S., Holsboer, F., & Rein, T. (2012) · Biochemical Journal · doi:10.1042/bj20120674 · Cited by 83
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
Berardis, D. D., Orsolini, L., Serroni, N., Girinelli, G., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Mazza, M., Valchera, A., Fornaro, M., et al. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150821103825 · Cited by 81
Hoepner, C. T., McIntyre, R. S., & Papakostas, G. I. (2021) · Nutrients · doi:10.3390/nu13030767 · Cited by 80
Lu, J., Xu, Y., Hu, W., Gao, Y., Ni, X., Sheng, H., & Liu, Y. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.053 · Cited by 75
Levitan, R. D., Shen, J., Jindal, R., Driver, H. S., Kennedy, S. H., & Shapiro, C. M. (2000) · Europe PMC (PubMed Central) · Cited by 74
Resler, G., Lavie, R., Campos, J., Mata, S., Urbina, M., García, A., Apitz, R., & Lima, L. (2008) · Neuroimmunomodulation · doi:10.1159/000151527 · Cited by 73
Lazarou, C., & Kapsou, M. (2010) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2010.01.003 · Cited by 71
Ghazizadeh‐Hashemi, M., Ghajar, A., Shalbafan, M., Ghazizadeh‐Hashemi, F., Afarideh, M., Malekpour, F., Ghaleiha, A., Ardebili, M. E., & Akhondzadeh, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.057 · Cited by 71
The role of the GPR39 receptor in zinc deficient-animal model of depression
Młyniec, K., Budziszewska, B., Reczyński, W., Sowa-Kućma, M., & Nowak, G. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.020 · Cited by 70
Hisaoka‐Nakashima, K., Kajitani, N., Kaneko, M., Shigetou, T., Kasai, M., Matsumoto, C., Yokoe, T., Azuma, H., Takebayashi, M., Morioka, N., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.057 · Cited by 67
Halbach, O. V. B. U., Krause, S., Medina, D. L., Sciarretta, C., Minichiello, L., & Unsicker, K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.025 · Cited by 66
Sahraian, A., Ghanizadeh, A. J., & Kazemeini, F. (2015) · Trials · doi:10.1186/s13063-015-0609-1 · Cited by 65
Grassi, D., Franz, H., Vezzali, R., Bovio, P. P., Heidrich, S., Dehghanian, F., Lagunas, N., Belzung, C., KRIEGLSTEIN, K. G., & Vogel, T. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx095 · Cited by 65
Coppens, C. M., Siripornmongcolchai, T., Wibrand, K., Alme, M. N., Buwalda, B., de Boer, S. F., Koolhaas, J. M., & Bramham, C. R. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00072 · Cited by 61
Xu, Y., & Liang, L. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.08.002 · Cited by 61
Karpova, N. N., Rantamäki, T., Lieto, A. D., Lindemann, L., Hoener, M. C., & Ċastrén, E. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9544-6 · Cited by 60
Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.005 · Cited by 60
A study of 5-hydroxytryptamine formation from L-tryptophan in the brain and other tissues
Weber, L. J., & Horita, A. (1965) · Biochemical Pharmacology · doi:10.1016/0006-2952(65)90044-4 · Cited by 60
Park, Y., Moon, H.-J., & Kim, S. H. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.018 · Cited by 59
Bedson, E., Bell, D., Carr, D., Carter, B., Hughes, D., Jorgensen, A., Lewis, H., Lloyd, K., McCaddon, A., Moat, S., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18480 · Cited by 59
Wang, P., Zhang, C., Lv, Q., Bao, C., Sun, H., Ma, G., Fang, Y., Yi, Z., & Cai, W. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2463-z · Cited by 58
Leschik, J., Gentile, A., Cicek, C., Péron, S., Tevosian, M., Beer, A., Radyushkin, K., Bludau, A., Ebner, K., Neumann, I., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102333 · Cited by 58 · cited 1×
“In addition, the selective BDNF overexpression in serotonergic terminals, effective in inducing antidepressant-like behavioral responses, serotonergic axonal sprouting and upregulated neurogenesis in the dentate gyrus, occluded further antidepressant-like action of fluoxetine [54], suggesting a ceiling effect in BDNF…”
BackgroundElesawy, B. H., Raafat, B. M., Muqbali, A. A., Abbas, A. M., & Sakr, H. F. (2021) · Brain Sciences · doi:10.3390/brainsci11020242 · Cited by 57
Zhou, J., Li, M., Wang, X., He, Y., Xia, Y., Sweeney, J. A., Kopp, R. F., Liu, C., & Chen, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.674273 · Cited by 56
Ginsberg, L. D., Oubré, A., & Daoud, Y. (2011) · PubMed · Cited by 55
Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant Action
Hutchinson, A. N., Deng, J. V., Cohen, S., & West, A. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2156-12.2012 · Cited by 53
Park, S. W., Seo, M. K., Lee, J. G., Hiền, L. T. T., & Kim, Y. H. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12609 · Cited by 53
Psychopharmacology of 5-HT1A receptors
Cowen, P. J. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00108-6 · Cited by 52
Folic acid ameliorates depression-like behaviour in a rat model of chronic unpredictable mild stress
Zhou, Y., Cong, Y., & Liu, H. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-0551-3 · Cited by 51
Paduchová, Z., Katrenčíková, B., Vaváková, M., Laubertová, L., Nagyová, Z., Garaiová, I., Ďuračková, Z., & Trebatická, J. (2021) · Nutrients · doi:10.3390/nu13041095 · Cited by 50
Creatinine and creatine in CSF: indices of brain energy metabolism in depression
�gren, H., & Niklasson, F. (1988) · Journal of Neural Transmission · doi:10.1007/bf01243575 · Cited by 49
Mocking, R. J. T., Verburg, H. F., Westerink, A. M., Assies, J., Vaz, F. M., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.027 · Cited by 48
BDNF Expression in Cortical GABAergic Interneurons
Tomás, F. J. B., Turko, P., Heilmann, H., Trimbuch, T., Yanagawa, Y., Vida, I., & Münster‐Wandowski, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051567 · Cited by 45
van der Stelt, H. M., Broersen, L. M., Olivier, B., & Westenberg, H. G. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1632-6 · Cited by 44
Musazzi, L., Rimland, J. M., Ieraci, A., Racagni, G., Domenici, E., & Popoli, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001685 · Cited by 44
Gene × environment interactions in the prediction of response to antidepressant treatment
Klengel, T., & Binder, E. B. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001459 · Cited by 44
Coley, E. J. L., Demaestri, C., Ganguly, P., Honeycutt, J. A., Peterzell, S., Rose, N., Ahmed, N., Holschbach, M., Trivedi, M. S., & Brenhouse, H. C. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00101 · Cited by 43
Antidepressant-like Effect of Fuzi Total Alkaloid on Ovariectomized Mice
Liu, L., Li, B., Zhou, Y., Wang, L., Tang, F., Shao, D., Jiang, X., Zhao, H., Cui, R., & Li, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12163fp · Cited by 42
Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
Lin, J.-C., Lee, M.-Y., Chan, M., Chen, Y.-C., & Chen, H. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4359-x · Cited by 42
Ryszewska-Pokraśniewicz, B., Mach, A., Skalski, M., Januszko, P., Wawrzyniak, Z. M., Poleszak, E., Nowak, G., Pilc, A., & Radziwoń-Zaleska, M. (2018) · Nutrients · doi:10.3390/nu10081014 · Cited by 42
Sarris, J. J., Byrne, G. J., Bousman, C., Stough, C. K. K., Murphy, J., MacDonald, P., Adams, L., Nazareth, S. M., Oliver, G., Cribb, L., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.07.098 · Cited by 41
Sadighparvar, S., Darband, S. G., Yousefi, B., Kaviani, M., Ghaderi‐Pakdel, F., Mihanfar, A., Babaei, G., Mobaraki, K., & Majidinia, M. (2020) · Experimental Physiology · doi:10.1113/ep088605 · Cited by 41 · cited 1×
“In rats with colorectal cancer and depressive-like behavior, treatment with quercetin and exercise improved anti-tumor and antidepressant effects by suppressing inflammatory markers and upregulating the BDNF/TrkB/ß-Catenin axis [190].”
BackgroundZinc deficiency alters responsiveness to antidepressant drugs in mice
Młyniec, K., Budziszewska, B., Reczyński, W., Doboszewska, U., Pilc, A., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71035-1 · Cited by 40
Nutritional strategies for dealing with depression
Manosso, L. M., Moretti, M., & Rodrigues, A. L. S. (2013) · Food & Function · doi:10.1039/c3fo60246j · Cited by 40
New insights on brain‐derived neurotrophic factor epigenetics: from depression to memory extinction
Poon, C. H., Heng, B. C., & Lim, L. W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14458 · Cited by 40 · cited 2×
“Moreover, both preclinical and clinical research show a close relationship between antidepressants and alterations in Bdnf expression, indicating that the Bdnf gene is a critical epigenetic target [42].”
BackgroundLi, B., Zhao, J., Lv, J., Tang, F., Liu, L., Sun, Z., Wang, L. Y., Siwela, S. P., Wang, Y., Song, Y., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.015 · Cited by 39
Vitamin D supplements in geriatric major depression
Zanetidou, S., Murri, M. B., Buffa, A., Malavolta, N., Anzivino, F., & Bertakis, K. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2703 · Cited by 38
The Way to a Human’s Brain Goes Through Their Stomach: Dietary Factors in Major Depressive Disorder
Aly, J. S., & Engmann, O. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.582853 · Cited by 38
Self-citationDoboszewska, U., Szewczyk, B., Sowa-Kućma, M., Młyniec, K., Rafało, A., Ostachowicz, B., Lankosz, M., & Nowak, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.064 · Cited by 37
Lin, J.-C., Chan, M., Lee, M.-Y., Chen, Y.-C., & Chen, H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.06.002 · Cited by 37
Differential BDNF methylation in combat exposed veterans and the association with exercise
Voisey, J., Lawford, B., Bruenig, D., Harvey, W., Morris, C. P., Young, R. M., & Mehta, D. (2019) · Gene · doi:10.1016/j.gene.2019.02.067 · Cited by 37
Yildirim, E. O., Erol, K., & Ulupınar, E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.017 · Cited by 35
Christensen, H. M., Aiken, A., Batterham, P. J., Walker, J. G., Mackinnon, A. J., Fenech, M. F., & Hickie, I. B. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.029 · Cited by 35
Sarris, J., Murphy, J., Stough, C., Mischoulon, D., Bousman, C., MacDonald, P., Adams, L., Nazareth, S., Oliver, G., Cribb, L., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05358-1 · Cited by 35
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression
Młyniec, K. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210225153404 · Cited by 35
Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes
Ilchibaeva, T., Tsybko, A., Zeug, A., Müller, F. E., Guseva, D., Bischoff, S., Ponimaskin, E., & Naumenko, V. (2022) · Cells · doi:10.3390/cells11152384 · Cited by 35
The Role of BDNF, Leptin, and Catecholamines in Reward Learning in Bulimia Nervosa
Homan, P., Grob, S., Milos, G. F., Schnyder, U., Eckert, A., Lang, U. E., & Hasler, G. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu092 · Cited by 33
Rafa–Zabłocka, K., Kreiner, G., Bagińska, M., & Nalepa, I. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00637 · Cited by 31
Able, J. A., Liu, Y., Jandacek, R. J., Rider, T., Tso, P., & McNamara, R. K. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.008 · Cited by 30
Bjørnebekk, A., Mathé, A. A., Gruber, S. H. M., & Brené, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008912 · Cited by 30
Berardis, D. D., Marini, S., Serroni, N., Rapini, G., Iasevoli, F., Valchera, A., Signorelli, M. S., Aguglia, E., Perna, G., Salone, A., et al. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/204649 · Cited by 29
Li, L., Wang, T., Chen, S., Yue, Y., Xu, Z., & Yuan, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.016 · Cited by 29
Li, Y., Ji, Y.-J., Jiang, H., Liu, D.-X., Zhang, Q., Fan, S.-J., & Pan, F. (2009) · PubMed · Cited by 28
Kim, T.-W., Lim, B., Kim, K.-J., Seo, J.-H., & Kim, C. (2015) · Journal of Exercise Rehabilitation · doi:10.12965/jer.150225 · Cited by 28
Brancato, A., Castelli, V., Cavallaro, A., Lavanco, G., Plescia, F., & Cannizzaro, C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00150 · Cited by 27
Self-citationTherapeutic response to paroxetine in major depressive disorder predicted by DNA Methylation
Takeuchi, N., Nonen, S., Kato, M., Wakeno, M., Takekita, Y., Kinoshita, T., & Kugawa, F. (2017) · Neuropsychobiology · doi:10.1159/000480512 · Cited by 26 · cited 1×
“Accordingly, diminished light exposure affects BDNF levels as well [186].”
BackgroundCunha, M. P., Pazini, F. L., Lieberknecht, V., & Rodrigues, A. L. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.001 · Cited by 26
Stapel, B., Fraccarollo, D., Westhoff‐Bleck, M., Bauersachs, J., Lichtinghagen, R., Jahn, K., Burkert, A., Buchholz, V., Bleich, S., Frieling, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11639-1 · Cited by 26
Cho, J.-W., Jung, S.-Y., Lee, S., Lee, S., Seo, T.-B., Kim, Y.-P., & Kim, D.-Y. (2017) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1735180.590 · Cited by 25
Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2
Trautmann, C., Bock, A., Urbach, A., Hübner, C. A., & Engmann, O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108112 · Cited by 25
Self-citationChang, H. S., Won, E., Lee, H.-Y., Ham, B., & Lee, M.-S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.005 · Cited by 24
Wearick-Silva, L. E., Orso, R., Martins, L. A., Creutzberg, K., Centeno-Silva, A., Xavier, L., Grassi-Oliveira, R., & Mestriner, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.025 · Cited by 24
Sial, O. K., Gnecco, T., Cardona-Acosta, A. M., Vieregg, E., Cardoso, E. A., Parise, L. F., & Bolaños‐Guzmán, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.701919 · Cited by 24
Micale, V., Scapagnini, G., Colombrita, C., Mazzola, C., Alkon, D. L., & Drago, F. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.11.006 · Cited by 23
Panizzutti, B., Bortolasci, C. C., Hasebe, K., Kidnapillai, S., Gray, L. J., Walder, K. R., Berk, M., Mohebbi, M., Dodd, S., Gama, C. S., et al. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2018.13 · Cited by 22
Furuse, K., Ukai, W., Hashimoto, E., Hashiguchi, H., Kigawa, Y., Ishii, T., Tayama, M., Deriha, K., Shiraishi, M., & Kawanishi, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.007 · Cited by 22
Cited by
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
Toader, C., Șerban, M., Munteanu, O., Covache-Busuioc, R.-A., Enyedi, M., Ciurea, A. V., & Tătaru, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094271 · Cited by 184
Cavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., & Bartoli, F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105159 · Cited by 146
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 104
Șerban, M., Toader, C., & Covache-Busuioc, R.-A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157498 · Cited by 73
Lei, M., Liu, Q., Nie, J., Huang, R., Mei, Y., Pan, D., Chen, Y., & Liu, W. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70138 · Cited by 70
Metadata
- Authors
- Cubillos, S., Engmann, O., & Brancato, A.
- Affiliations
- Friedrich Schiller University Jena (DE)
- University of Palermo (IT)
- Corresponding author
- Engmann, Olivia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-11-21
- Volume
- 23
- Issue
- 22
- Pages
- 14445
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9698349
- OpenAlex
- W4309787614
- Cited by
- 47
- References
- 214
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 13 · 2023: 12
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS UniPA (University of Palermo) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Common Library Network (Der Gemeinsame Bibliotheksverbund) (submittedVersion, cc-by)
- Funders
- Carl-Zeiss-Foundation (#P2019-01-0006, 737/2021, FFR 2019/2022)
- European Union—NextGenerationEU (#P2019-01-0006, 737/2021, FFR 2019/2022)
- University of Palermo (#P2019-01-0006, 737/2021, FFR 2019/2022)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, antidepressant response, antidepressant mechanism, BDNF signaling, lifestyle factors, nutrition, environmental factors, physiological factors, antidepressant drug development
- MeSH terms
- Antidepressive Agents, Signal Transduction, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.